Terms: = Kidney tumors AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
43 results:
1. Unleashing the link between the relaxation of the COVID-19 control policy and residents' mental health in China: the mediating role of family tourism consumption.
He Y; Zhan S; Su H; Deng Y
Front Public Health; 2023; 11():1216980. PubMed ID: 37674676
[TBL] [Abstract] [Full Text] [Related]
2. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ; Noureddin N; Ajmera V; Amangurbanova M; Bettencourt R; Truong E; Gidener T; Siddiqi H; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Yoneda M; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Allen AM; Noureddin M; Loomba R
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):829-836. PubMed ID: 37419133
[TBL] [Abstract] [Full Text] [Related]
3. Second malignant tumors and non-tumor causes of death for patients with localized and regional kidney cancer after diagnosis.
Yang L; Wu X; Zhou J; Song P; Liu Z; Chen J; Dong Q
Eur J Med Res; 2023 Jun; 28(1):206. PubMed ID: 37391781
[TBL] [Abstract] [Full Text] [Related]
4. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
5. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States.
Lai Y; Bensimon AG; Gao E; Bhattacharya R; Xu R; Chevure J; Imai K; Haas NB
Clin Genitourin Cancer; 2023 Oct; 21(5):612.e1-612.e11. PubMed ID: 37137809
[TBL] [Abstract] [Full Text] [Related]
6. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.
Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
[TBL] [Abstract] [Full Text] [Related]
7. Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.
Dawsey SJ; Campbell SC; Ornstein MC
Curr Oncol; 2021 May; 28(3):1921-1926. PubMed ID: 34065284
[TBL] [Abstract] [Full Text] [Related]
8. Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy.
Erne E; Kruck S; Todenhoefer T; Aufderklamm S; Amend B; Bedke J; Stenzl A; Rausch S
Surg Endosc; 2022 Jan; 36(1):663-669. PubMed ID: 33591449
[TBL] [Abstract] [Full Text] [Related]
9. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
Bearrick EN; Packiam V; Bhindi B; Lohse CM; Cheville JC; Mason RJ; Tollefson M; Harrington S; Dong H; Parker AS; Boorjian SA; Thompson RH; Leibovich BC
Urol Oncol; 2021 Feb; 39(2):135.e1-135.e8. PubMed ID: 33309297
[TBL] [Abstract] [Full Text] [Related]
10. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract] [Full Text] [Related]
12. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract] [Full Text] [Related]
13. Height as a mediator of sex differences in cancer risk.
Fu BC; Song M; Li X; Han J; Adami HO; Giovannucci EL; Mucci LA
Ann Oncol; 2020 May; 31(5):634-640. PubMed ID: 32217057
[TBL] [Abstract] [Full Text] [Related]
14. Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review.
Zhou X; Liu M; Ren Q; Zhu W; Wang Y; Chen H; Chen J
BMC Complement Altern Med; 2019 Dec; 19(1):366. PubMed ID: 31830977
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results.
Selvi I; Demirci U; Bozdogan N; Basar H
Int Urol Nephrol; 2020 Jan; 52(1):21-34. PubMed ID: 31541404
[TBL] [Abstract] [Full Text] [Related]
16. Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility.
Huang L; Li MQ; Ou C; Huang WC; Liu JF; Huang H
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1105-S1109. PubMed ID: 30539853
[TBL] [Abstract] [Full Text] [Related]
17. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade.
Shu J; Tang Y; Cui J; Yang R; Meng X; Cai Z; Zhang J; Xu W; Wen D; Yin H
Eur J Radiol; 2018 Dec; 109():8-12. PubMed ID: 30527316
[TBL] [Abstract] [Full Text] [Related]
18. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
19. In-hospital length of stay after major surgical oncological procedures.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Saad F; Graefen M; Tilki D; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2018 Jul; 44(7):969-974. PubMed ID: 29784507
[TBL] [Abstract] [Full Text] [Related]
20. Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients.
Kim YH; Han K; Oh YT; Jung DC; Cho NH; Park SY
Abdom Radiol (NY); 2018 Mar; 43(3):647-654. PubMed ID: 28677004
[TBL] [Abstract] [Full Text] [Related]
[Next]
